These findings are in accordance with previous evidence obtained both in vitro and in vivo indicating that IGF1 triggers VEGF-mediated neovascularization in breast, endometrial, head and neck, lung, colon cancer and sarcoma cells [13–16, 32, 34]. This evidence concerns the gene IGF1 and colonic neoplasm.